Hap Trading, LLC Mirati Therapeutics, Inc. Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$41.27 - $98.62 $559,373 - $1.34 Million
13,554 New
13,554 $614,000
Q4 2019

Feb 11, 2020
BUY
$70.76 - $128.86 $1.47 Million - $2.68 Million
20,801 Added 144.94%
35,152 $4.53 Million
Q1 2019

May 10, 2019
BUY
$43.65 - $78.95 $626,421 - $1.13 Million
14,351 New
14,351 $1.05 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email